Next-Generation Sonogenic Stimulation for Neural Circuit Modulation

Publication ID: 24-11857809_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Sonogenic Stimulation for Neural Circuit Modulation,” Published Technical Disclosure No. 24-11857809_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857809_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,809.

Summary of the Inventive Concept

A system and method for modulating neural circuits using ultrasound, enabling targeted and spatially-precise control of neural activity, with potential applications in treating neurological disorders and enhancing cognitive function.

Background and Problem Solved

The original patent disclosed a method for altering neural activity using ultrasound, but had limitations in terms of spatial resolution and specificity. The new inventive concept addresses these limitations by introducing a micro-TRP4 expression vector for spatially-targeted expression of TRP4 polypeptides, enabling more precise control of neural activity.

Detailed Description of the Inventive Concept

The new inventive concept comprises a neural interface device, a micro-TRP4 expression vector, and an ultrasound transducer array. The micro-TRP4 expression vector is configured to express TRP4 polypeptides in a spatially-targeted manner within the neural circuit, allowing for precise control of neural activity. The ultrasound transducer array applies ultrasound energy to the targeted tissue portion, stimulating the TRP4-expressing neurons. The system can be used to modulate neural circuits, generate neural maps, and treat neurological disorders.

Novelty and Inventive Step

The new claims introduce the concept of spatially-targeted expression of TRP4 polypeptides using a micro-TRP4 expression vector, which is not disclosed in the original patent. This enables more precise control of neural activity and represents a significant advancement over the original invention.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different ultrasound frequencies, pulse durations, or spatial patterns to modulate neural activity. Additionally, the system could be adapted for use in other applications, such as neural prosthetics or brain-computer interfaces.

Potential Commercial Applications and Market

The inventive concept has potential applications in the treatment of neurological disorders, such as Parkinson's disease, epilepsy, and depression, as well as in enhancing cognitive function. The market for neural modulation technologies is rapidly growing, with an estimated value of $10 billion by 2025.

Original Patent Information

Patent NumberUS 11,857,809
TitleSonogenic stimulation of cells
Assignee(s)Salk Institute for Biological Studies